Session: SARS: Response to a Global Epidemic
3055.0: Monday, November 17, 2003: 8:30 AM-10:00 AM
Oral
SARS: Response to a Global Epidemic
Severe Acute Respiratory Syndrome (SARS) was first reported in the Guangdong Province of southern China in November 2002. The subsequent search for the causative agent and ways to prevent and treat SARS has become a case study in the emergence of a global infectious disease and a critical lesson in the importance of public health surveillance, biodefense, and international cooperation. The sessionís three speakers will address the global public health aspects of the SARS epidemic and the competition and cooperation to identify and sequence the SARS virus and develop treatments and vaccines. Additional topics to be covered include quarantines and travel advisories, the need for effective public health infrastructure and surveillance systems, and predictions of the future of SARS. Speakers: Dr Tomas Aragon, Director, Center of Infectious Disease Preparedness, University of California, Berkeley; Dr. Rima Khabbaz, Associate Director for Epidemiologic Science, National Center for Infectious Disease, CDC; Dr. Art Reingold, Chair of the Department of Epidemiology, University of California, Berkeley
Learning Objectives: Refer to the individual abstracts for learning objectives
See individual abstracts for presenting author's disclosure statement and author's information.
Moderator(s):Kate Tulenko, MD, MPH, M Phil
8:30 AMPresentation by the Director of the Center of Infectious Disease Preparedness at the University of California, Berkeley
Tomas Aragon
8:50 AMPresentation by the Associate Director for Epidemiologic Science, National Center for Infectious Disease, CDC
Rima Khabbaz
9:10 AMPresentation by the Chair of the Department of Epidemiology, University of California, Berkeley
Art Reingold
Organized by:International Health
Endorsed by:Asian Pacific Islander Caucus of APHA; Socialist Caucus
CE Credits:CME, Health Education (CHES), Nursing, Pharmacy

The 131st Annual Meeting (November 15-19, 2003) of APHA